First Trust Nasdaq Pharmaceuticals ETF
AJM Ventures LLC FTXH ETF
FTXH Price | $27.25 |
Market Cap | $15M |
Annual Dividend Yield | 1.63% |
Annual Dividend | $0.45 |
Yearly Management Fee | 0.60% |
Asset Class | Equity |
Focus | Health care |
Category | Sector, Health Care |
Niche | Pharmaceuticals |
Last 24h Volume | $495 |
Portfolio Management Company | AJM Ventures LLC |
Discount/Premium to NAV | 0.04% |
Inception Date | Sep 20, 2016 |
Market Cap Rank | 3126 |
Monthly AUM Growth | -7.90% |
Holdings Region | North America |
Management Style | Passive |
Leverage | Non-Leveraged |
First Trust Nasdaq Pharmaceuticals ETF is an ETF issued by AJM Ventures LLC on Sep 20 2016.
The main focus of this ETF, which is in the "Equity" asset class, is determined as "Health care".
As of today, the price of FTXH ETF according to its net asset value is premiumed at 0.04%.
While the total value of the fund shows $-1,286,500 decrease compared to the previous month, its price is traded daily at a decrease of -0.91%.
The annual dividend yield of FTXH ETF is 1.63%, whereas its main asset area is North America.
FTXH ETF, whose 24-hour total volume is $495, has experienced a $-1,413,900 cash outflow in the last month.
In addition, First Trust Nasdaq Pharmaceuticals ETF's one-year net asset value total return is 4.38%.
FTXH ETF Returns
Daily |
Weekly |
Monthly |
3 Mo |
6 Mo |
YTD |
Yearly |
-0.91% |
-1.59% |
0.74% |
-8.22% |
-0.95% |
2.10% |
3.97% |
FTXH ETF NAV Total Return
Monthly |
3 Mo |
YTD |
Yearly |
3 Years |
5 Years |
1.34% |
-6.35% |
3.66% |
4.38% |
5.66% |
22.65% |
FTXH ETF Fund Flows Chart
FTXH ETF Market Cap Chart
FTXH ETF NAV Growth Chart
FTXH ETF Comments
no comments yet